Inactive Instrument
Vivesto AB Share Price OTC Markets
Stocks
OASMY
US67421W1099
Pharmaceuticals
OTC Markets Traded| Market Cap | 8.03Cr 78.73L 71.73L 66.4L 60.07L 1.13Cr 74Cr 1.18Cr 3.18Cr 40Cr 2.95Cr 2.89Cr 125.87Cr | P/E 2026 * |
-2.59x | P/E 2027 * | -2.06x |
|---|---|---|---|---|---|
| Enterprise Value | 6.93Cr 67.94L 61.9L 57.3L 51.83L 97.24L 63Cr 1.02Cr 2.75Cr 34Cr 2.55Cr 2.5Cr 108.62Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -99.00% | - | - | 78.73L | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,20400Cr | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 64TCr | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 50TCr | ||
| -0.51% | -1.38% | +28.00% | +68.29% | 38TCr | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 33TCr | ||
| +0.22% | -4.54% | +27.44% | +51.85% | 28TCr | ||
| +0.90% | -3.70% | -1.36% | +33.23% | 27TCr | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 24TCr | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 21TCr | ||
| Average | -1.06% | -4.40% | +26.04% | +75.74% | 45TCr | |
| Weighted average by Cap. | -1.50% | -4.71% | +27.12% | +88.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.8Cr -27.47L -25.02L -23.16L -20.95L -39.31L -26Cr -41.14L -1.11Cr -14Cr -1.03Cr -1.01Cr -44Cr | -3.9Cr -38.25L -34.85L -32.26L -29.18L -54.75L -36Cr -57.3L -1.55Cr -19Cr -1.44Cr -1.41Cr -61Cr |
| Net Debt | -1.1Cr -10.79L -10L -9L -8L -15.44L -10Cr -16.16L -43.63L -5.45Cr -40.48L -39.63L -17Cr | -2Cr -19.62L -17.87L -16.55L -14.97L -28.08L -18Cr -29.39L -79.33L -9.9Cr -73.6L -72.06L -31Cr |
Employees
4
Sector
Pharmaceuticals
















